Insys Therapeutics (INSY) Return on Assets ROA from the first quarter of 2019 to first quarter of 2018 and for the year 2019, Average High and Low, Fundamental Ratios from Mar 31 2019 to Mar 31 2018 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Insys Therapeutics, Inc.  (INSY)


Insys Therapeutics's ROA from the first quarter of 2019 to the first quarter of 2018 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Insys Therapeutics's ROA in the first quarter of 2019?
Insys Therapeutics, Inc. recorded a cumulative net loss of $-228 million during 12 months ending in the first quarter of 2019, resulting in a negative return on assets (ROA) of -111.51%.

However, within the Healthcare sector 717 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2019 quarter, so far to 4727, from total ROA ranking in the fourth quarter of 2018 at 4894.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter		 (Mar 31 2018)
I. Quarter
Y / Y Total Assets Change -32.03 % -53.61 % -32.68 % -30.35 % -24.78 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -228 -125 -124 -260 -241
Return On Assets (TTM) -111.51 % -55.39 % -44.27 % -84.74 % -72.44 %
INSY's Total Ranking # 4727 # 4894 # 4303 # 4628 # 4648
Total Assets (TTM) in million 173 193 217 235 254
Seq. Total Assets Change -10.35 % -11.48 % -7.51 % -7.4 % -38.81 %
Seq. Net Income Change - - - - -

INSY's 5 Years Annual ROA >> Back to INSY Management Effectiveness >> Compare INSY ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 361
Sector # 718
Overall # 4513

Return On Assets Statistics
High Average Low
36.82 %
-13.05 %
-111.51 %
(Dec 31 2013)   (Mar 31 2019)





Financial Statements
Insys Therapeutics's Assets $ 173 million INSY's Balance sheet
Insys Therapeutics's Income $ -124 million Quarterly INSY's Income Statement
INSY's Income by Division See INSY's Income by Division



Annual Return On Assets (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016		 (Dec 31 2015)
FY 2015		 (Dec 31 2014)
FY 2014
Y / Y Total Assets Change -31.01 % -32.5 % 17.73 % 63.26 % 114.53 %
Total Assets in million 193 279 413 351 215
Y / Y Net Income Change - - -87.02 % 53.98 % -5.94 %
Net Income in million -125 -228 8 58 38
Annual Return On Assets -64.67 % -81.7 % 1.84 % 16.65 % 17.65 %

INSY's 5 Years Annual ROA >> Back to INSY Management Effectiveness >> Compare INSY ROA to its Competitors



More Return On Assets Ratios
INSY's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
INSY's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for INSY's Competitors
Subscribers only: Roa for Insys Therapeutics's Suppliers
Subscribers only: Return On Assets for INSY's Customers

You may also want to know
INSY's Roi INSY's Inventory Turnover Ratio INSY's Growth Rates INSY's Dividend Comparisons
INSY's Profitability Ratios INSY's Asset Turnover Ratio INSY's Dividend Growth
INSY's Roe INSY's Valuation Ratios INSY's Financial Strength Ratios INSY's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2019, within Healthcare Sector ROA

Date modified: 2026-09-12T06:13:29+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.